全球舍曲林市场 - 行业趋势和 2029 年预测

市场分析与洞察全球舍曲林市场

预计舍曲林市场将在 2022-2029 年的预测期内实现市场增长。Data Bridge Market Research 分析称，在上述预测期内，市场复合年增长率将达到 3.90%。

舍曲林是一种抗抑郁药，属于选择性血清素再摄取抑制剂 (SSRI) 类药物。它通过增加大脑中的血清素活性水平发挥作用。它是一种处方药，有多种剂型，包括片剂、溶液和胶囊。它也有仿制药。左洛复是这种药物的品牌名。这种药物有助于治疗强迫症、恐慌症、抑郁症、神经性贪食症和经前焦虑症等。

全世界焦虑症和强迫症患病率的上升将成为舍曲林市场扩张的主要驱动力。此外，老年人口的增加、医疗支出的增加以及抑郁症患者数量的增加都是扩大舍曲林市场的因素。其他因素包括对抗抑郁药需求的增加、生活方式的改变和意识的提高，都将对市场增长率产生积极影响。另一个重要因素是与舍曲林一起治疗精神疾病相关的技术创新的增加，例如重复经颅磁刺激疗法 (rTMS)、经颅磁刺激疗法 (TMS) 等，将缓冲市场的增长率。

Moreover, the rise in the research and development activities, new product launches and strategic collaborations will provide beneficial opportunities for the sertraline market in the forecast period of 2021-2028.

However, high cost of the drug and side effects associated with sertraline such as loss of appetite, eye pain, diarrhea, loss of coordination, headache, nausea, dizziness, seizures and others. All these factors hamper the market growth. Lack of awareness will further challenge the sertraline market in the forecast period mentioned above.

This sertraline market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the sertraline market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Sertraline Market Scope and Market Size

The sertraline market is segmented on the basis of strength, drug class, application, demographic, dosage form, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of strength, the sertraline market is segmented into 20mg, 25mg, 50mg, and 100mg
• On the basis of drug class, the sertraline market is segmented into antidepressant, selective serotonin reuptake inhibitor (SSRI).
• On the basis of application, the sertraline market is segmented into obsessive-compulsive disorder, panic disorder, depression, premenstrual anxiety disorder and others.
• On the basis of demographic, the sertraline market is segmented into adult, pediatric and geriatric.
• On the basis of dosage form, the sertraline market is segmented into tablet, solution, capsule, and others.
• On the basis of route of administration, the sertraline market is segmented into oral and others.
• On the basis of end-users, the sertraline market is segmented into clinic, hospital and others.

The sertraline market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Sertraline Market Country Level Analysis

The sertraline market is segmented on the basis of strength, drug class, application, demographic, dosage form, route of administration, end-users and distribution channel.

The countries covered in the sertraline market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the sertraline market due to the presence of major key players, high disposable income and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to the increasing research and development activities and growing government support in this region.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Sertraline market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Sertraline Market Share Analysis

Sertraline market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to sertraline market research.

舍曲林市场的一些主要参与者包括 Teva Pharmaceutical Industries Ltd.、Aurobindo Pharma、Mylan NV、Apotex Inc.、Sun Pharmaceutical Industries Ltd.、Lupin、Torrent Pharmaceuticals Ltd.、Pfizer Inc.、Novartis AG、Accord Healthcare、Cipla Inc.、WOCKHARDT、Gerot Lannach、DAIICHI SANKYO COMPANY, LIMITED、浙江京新药业有限公司、Oxford Pharma、Allergan、Unimarck Pharma India Limited、Mitsubishi Tanabe Pharma Corporation、Genericon Pharma GmbH 和 ANGITA 等。

SKU-67400